Cerevel Therapeutics to be Acquired by AbbVie for $8.7 Billion NewsbysupervisorDecember 6, 20231 minute readNo comments
Concerns about the 2024 GOP Presidential Nomination NewsbysupervisorDecember 6, 20232 minute readNo comments
News Novartis Exceeds Expectations: Raises Outlook and Announces $15 Billion Share Buyback Novartis, the Swiss pharmaceutical company, experienced a surge in its stock during early trading on Tuesday following an… supervisorJuly 19, 2023 Read More
